| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |